All Vaccinology articles – Page 11
-
NewsAdvances in priming B cell immunity against HIV pave the way to future HIV vaccines, new studies show
Scientists have made several advances in the design of a class of HIV vaccines that could offer broad protection against the virus, according to four new research papers published this week.
-
NewsHPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows
The human papillomavirus, or HPV, vaccine is cutting cases of cervical cancer right across the socio-economic spectrum, with most cases being prevented in more deprived groups, according to a major study funded by Cancer Research UK. Source: NIAID Colorized electron micrograph of HPV virus particles harvested and ...
-
NewsBiophysicist F. William Studier awarded Merkin prize in biomedical technology
F. William Studier, a senior biophysicist emeritus at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory, has won the 2024 Richard N. Merkin Prize in Biomedical Technology for his development in the 1980s of an efficient, scalable method of producing RNA and proteins in the laboratory. Source: ...
-
NewsBirth by C-section more than doubles odds of measles vaccine failure
Researchers say it is vital that children born by caesarean section receive two doses of the measles vaccine for robust protection against the disease.
-
NewsGPS-like system shows promise as HIV vaccine strategy to elicit critical antibodies
Researchers have developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.
-
NewsUT Health San Antonio to lead $11m study of a first-ever oral chlamydia vaccine
The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant.
-
NewsA third Covid vaccine dose improves defence for some clinically extremely vulnerable patients
A major clinical trial has found that an additional COVID 19 vaccine dose led to the majority of clinically extremely vulnerable people mounting defensive antibodies against Covid-19.
-
NewsInternational Vaccine Institute, Baylor College of Medicine, and Regional Center for Innovation in Vaccines and Biopharmaceuticals AIP exchange an MOU
The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, Baylor College of Medicine (Baylor), health science university and a Texas nonprofit corporation, and the Regional Center for Innovation in Vaccines and Biopharmaceuticals (CRIVB) AIP, a ...
-
NewsAn adjuvant made in yeast could lower vaccine cost and boost availability
Scientists have wielded the power of synthetic biology to produce the active ingredient of soap bark, a molecule called QS-21, in yeast - a more environmentally friendly way to produce a key ingredient of vaccines.
-
NewsMobile teams bring COVID-19 vaccines to rural villages in Sierra Leone
A new international research project showed that intervention with mobile vaccination teams in Sierra Leone is an effective way of reaching rural populations to increase vaccination uptake.
-
NewsNew vaccine effective against coronaviruses that haven’t even emerged yet
Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks - including ones we don’t even know about.
-
NewsStudy identifies immunity threshold for protection against COVID-19 in children
Researchers have found rather than antibodies, other arms of the immune system – T cells and memory B cells – provide durable protection against symptomatic SARS-CoV-2 infection in children.
-
NewsRotavirus vaccinations in NICU pose minimal risk, study reveals
Rotavirus vaccines do not cause significant outbreaks of the disease in neonatal intensive care units (NICUs), according to a new study.
-
NewsNew strategy could lead to universal, long-lasting flu shot
Researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable.
-
NewsA significant portion of the world’s population continues to trust vaccines, says survey in 23 countries
A substantial proportion of the world’s population remains willing to get vaccinated against diseases including COVID-19, according to a new survey across 23 countries that represent more than 60% of the world’s population.
-
NewsStaying current with COVID-19 vaccinations helps combat emerging variants
The study is among the first to test in a biosafety level 3 laboratory whether vaccine-elicited antibodies block infection of a live virus.
-
NewsGlobal measles cases almost double in a year
Measles outbreaks are still occurring and in some cases increasing, among a wide variety of countries, raising concerns of an acceleration similar to just before the COVID pandemic. Dr Patrick O’Connor, of WHO Headquarters, Geneva, Switzerland will give an overview of the global measles situation at this ...
-
NewsNegativity about vaccines surged on Twitter after COVID-19 jabs become available
There was a marked increase in negativity about vaccines on Twitter after COVID-19 vaccines became available, while spikes in the number of negative tweets coincided with announcements from healthcare authorities about vaccination.
-
NewsUndocumented Latinx patients got COVID-19 vaccine at same rate as US citizens
For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study has found. These findings surprised researchers, given that COVID-19 disproportionately affected the Latinx ...
-
NewsCervical cancer vaccine very effective in reducing HPV-related disease, but huge variations between countries in coverage
Although evidence is clear that HPV vaccination is reducing cervical cancer incidence and mortality and HPV-related disease, there are high variations in coverage globally, including among high-income countries.